ProfileGDS4718 / 201873_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 73% 80% 77% 82% 93% 94% 83% 70% 85% 87% 71% 94% 94% 92% 87% 83% 91% 91% 90% 82% 83% 81% 84% 88% 93% 82% 92% 79% 95% 91% 92% 63% 78% 85% 92% 94% 86% 79% 84% 81% 93% 87% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4591785
GSM549102patient 115, normal, homogenized [OPG study]7.055873
GSM549104patient 119, normal, homogenized [OPG study]7.8752480
GSM549108patient 138, normal, homogenized [OPG study]7.3978977
GSM549119patient 077, normal, homogenized [OPG study]8.0097282
GSM549133patient 032, cancer, homogenized [OPG study]9.8236193
GSM549139patient 042, cancer, homogenized [OPG study]9.9036194
GSM549099patient 107, normal, homogenized [OPG study]8.0941783
GSM549109patient 139, normal, homogenized [OPG study]6.8631370
GSM549110patient 046, normal, homogenized [OPG study]8.4180685
GSM549114patient 063, normal, homogenized [OPG study]8.8275387
GSM549122patient 082, normal, homogenized [OPG study]7.0014571
GSM549134patient 033, cancer, homogenized [OPG study]9.8643894
GSM549136patient 036, cancer, homogenized [OPG study]10.037894
GSM549140patient 044, cancer, homogenized [OPG study]9.578992
GSM549111patient 047, normal, homogenized [OPG study]8.8109587
GSM549113patient 057, normal, homogenized [OPG study]8.3064283
GSM549132patient 031, cancer, homogenized [OPG study]9.3965191
GSM549137patient 038, cancer, homogenized [OPG study]9.3501491
GSM549142patient 047, cancer, homogenized [OPG study]8.7234290
GSM549100patient 110, normal, homogenized [OPG study]8.0003182
GSM549107patient 135, normal, homogenized [OPG study]8.302783
GSM549115patient 068, normal, homogenized [OPG study]8.0908881
GSM549116patient 072, normal, homogenized [OPG study]8.4389184
GSM549120patient 078, normal, homogenized [OPG study]8.865788
GSM549131patient 030, cancer, homogenized [OPG study]9.7710393
GSM549118patient 074, normal, homogenized [OPG study]8.0620982
GSM549129patient 027, cancer, homogenized [OPG study]9.3798192
GSM549123patient 088, normal, homogenized [OPG study]7.7809379
GSM549124patient 006, cancer, homogenized [OPG study]10.126495
GSM549126patient 015, cancer, homogenized [OPG study]9.3052991
GSM549128patient 025, cancer, homogenized [OPG study]9.5249892
GSM549103patient 117, normal, homogenized [OPG study]6.3275163
GSM549117patient 073, normal, homogenized [OPG study]7.6707978
GSM549138patient 041, cancer, homogenized [OPG study]8.4825985
GSM549141patient 045, cancer, homogenized [OPG study]9.62992
GSM549130patient 028, cancer, homogenized [OPG study]9.8988694
GSM549101patient 111, normal, homogenized [OPG study]8.5109186
GSM549105patient 128, normal, homogenized [OPG study]7.6924779
GSM549106patient 134, normal, homogenized [OPG study]8.5375384
GSM549112patient 048, normal, homogenized [OPG study]7.9982981
GSM549125patient 011, cancer, homogenized [OPG study]9.7574393
GSM549127patient 024, cancer, homogenized [OPG study]8.6454187
GSM549135patient 035, cancer, homogenized [OPG study]9.5594992